Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Total Liabilities (2016 - 2025)

InspireMD's Total Liabilities history spans 16 years, with the latest figure at $14.2 million for Q4 2025.

  • For Q4 2025, Total Liabilities rose 32.48% year-over-year to $14.2 million; the TTM value through Dec 2025 reached $14.2 million, up 32.48%, while the annual FY2025 figure was $14.2 million, 32.48% up from the prior year.
  • Total Liabilities reached $14.2 million in Q4 2025 per NSPR's latest filing, down from $14.4 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $14.4 million in Q3 2025 to a low of $4.7 million in Q1 2021.
  • Average Total Liabilities over 5 years is $8.2 million, with a median of $7.0 million recorded in 2022.
  • Peak YoY movement for Total Liabilities: fell 2.83% in 2023, then surged 57.26% in 2025.
  • A 5-year view of Total Liabilities shows it stood at $6.2 million in 2021, then grew by 17.48% to $7.3 million in 2022, then increased by 12.15% to $8.1 million in 2023, then skyrocketed by 31.68% to $10.7 million in 2024, then skyrocketed by 32.48% to $14.2 million in 2025.
  • Per Business Quant, the three most recent readings for NSPR's Total Liabilities are $14.2 million (Q4 2025), $14.4 million (Q3 2025), and $13.1 million (Q2 2025).